Di Nuzzo Private Wealth, Inc. Neogenomics Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $634 Million
- Q3 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 11 shares of NEO stock, worth $170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 6
83.33%
Holding current value
$170
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NEO
# of Institutions
276Shares Held
127MCall Options Held
581KPut Options Held
115K-
Black Rock Inc. New York, NY19.7MShares$304 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$218 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$136 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$104 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$102 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.94B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...